EI
VSTM icon

EAM Investors’s Verastem VSTM Stock Holding History

EAM Investors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,750
Closed -$1.5M – 400
2021
Q2 		$1.5M Buy
+30,750
New +$1.28M 0.23% 223
2020
Q2 		– Sell
-18,147
Closed -$575K – 329
2020
Q1 		$575K Buy
+18,147
New +$455K 0.18% 191
2018
Q3 		– Sell
-39,822
Closed -$3.29M – 377
2018
Q2 		$3.29M Buy
+39,822
New +$2.44M 0.52% 69
2017
Q4 		– Sell
-37,085
Closed -$2.09M – 350
2017
Q3 		$2.09M Buy
+37,085
New +$1.75M 0.28% 184
2013
Q4 		– Sell
-13,238
Closed -$1.98M – 359
2013
Q3 		$1.98M Buy
13,238
+4,887
+59% +$853K 0.39% 71
2013
Q2 		$1.39M Buy
+8,351
New +$1.01M 0.3% 112

Other funds holding VSTM

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

EAM Investors's VSTM Position: Q3 2021 in Review

EAM Investors sold out of Verastem (VSTM) in Q3 2021, closing a stake of 30,750 shares — an estimated $1.5M sold.

EAM Investors first reported a position in VSTM in Q2 2013 and held it in 6 quarters. The position peaked at $3.29M in Q2 2018. 147 funds tracked by Wall St. Rank hold VSTM as of Q3 2021.

  • EAM Investors reported no remaining Verastem position as of Q3 2021 after selling out during the quarter.
  • EAM Investors sold 30,750 Verastem shares in Q3 2021, an estimated $1.5M.
  • EAM Investors first reported a position in Verastem in Q2 2013 and held it in 6 quarters.
  • EAM Investors's Verastem position peaked at $3.29M in Q2 2018.
  • 147 funds tracked by Wall St. Rank held Verastem as of Q3 2021.

Based on EAM Investors's 13F filing for Q3 2021, filed 12 Nov 2021.